Skip to main content
. 2023 Jul 19;37(9):7317–7324. doi: 10.1007/s00464-023-10278-5

Table 2.

Pathology

Pathology Open Minimally invasive P-value
Tumor type
  Intestinal-type adenocarcinoma 25 51.0% 16 34.0% 0.366*
  Diffuse-type adenocarcinoma 19 38.8% 26 55.3%
  Carcinoid 1 2.0% 1 2.1%
  Signet cell carcinoma 3 6.1% 1 2.1%
  Other 1 2.0% 6 12.8%
Pathological T-stage 0.937*
  T0 (complete regression) 4 8.2% 3 6.4%
  Tis 2 4.1% 1 2.1%
  T1 8 16.3% 6 12.8%
  T2 4 8.2% 5 10.6%
  T3 19 38.8% 17 36.2%
  T4 12 24.5% 15 31.9%
Pathological N-stage 0.323**
  N0 23 46.9% 20 42.6%
  N1 13 26.5% 7 14.9%
  N2 8 16.3% 8 17.0%
  N3 5 10.2% 12 25.5%
Number of examined LN per patient 44.3  ± 16.7 40.7  ± 16.3 0.209
  N patients > 15 LN resected 48 98.0% 46 97.9% 0.742
Adherence to lymphadenectomy (based on pathology)
   < D1 lymphadenectomy 7 15% 3 6%
  D1 lymphadenectomy 14 30% 17 36%
  D1 + lymphadenectomy 12 26% 14 30%
  D2 lymphadenectomy 14 30% 13 28%